BioDeakin staff profiles
Dr Rupinder Kanwar
Position: Research Fellow
Phone: +61 3 522 72420
Dr RK Kanwar has extensive training and expertise in applying cutting edge techniques of immunology, cell biology, molecular biology to study the pathophysiology and therapeutic targets of human cancer and chronic inflammatory diseases (atherosclerosis, asthma and multiple sclerosis) in both in vivo and in vitro models. Dr Kanwar also has skills in delivering industry oriented research and is a key inventor in recent patent applications (4 international PCTs and one provisional filed) on devising treatments for chronic inflammatory diseases. Her current research focus is on combining nanomedicinal approaches with basic cell biology and immunology research, to devise diagnostics and therapeutics for cancer (angiogenesis, metastasis) and chronic inflammatory disease (atherosclerosis, asthma and osteoarthritis).
- PhD Medical Microbiology & Immunology (Postgraduate Inst of Medical Education & Research (PGIMER), Chandigarh, India-1994)
- MSc , Medical Microbiology (College of Basic Sciences & Humanities, PAU, India-1988)
- BSc Medical (Punjab University, India -1985)
Relevant employment history:
- 2006 - Present: Research Fellow, Immunology & Cell Biology, Deakin University, Australia.
- 2005 -2006: Senior Research Fellow, The University of Auckland, New Zealand.
- 1999- 2005 (June): Research Fellow, The University of Auckland, New Zealand .
- 1995-1996: Research Associateship (Postdoc) Award, Council of Scientific and Industrial Research, (CSIR) New Delhi, India.
- 1993-1994: Senior Research Fellowship, Council of Scientific and Industrial Research, (CSIR) New Delhi, India.
- 1991-1992: Junior Research Fellowship, PGIMER, India.
- 1989-1990: Junior Research Fellowship, Indian Council of Medical Research (ICMR), New Delhi, India
A list of the ten most significant relevant publications for the last five years:
- Kanwar JR, Mahidhara G and Kanwar RK (2009). Recent advances in nanoneurology for drug delivery to the brain. Currt Nanoscience. (In press).
- Puri M, Kaur I, Kanwar RK, Gupta RC, Chauhan AK, Kanwar JR (2009). Ribosome inactivating proteins for antiviral therapy. Curr. Mol. Med. (In press).
- Sara B, Kanwar RK., Khoshmanesh K, Punj, V, Chauhan, A, Matta, H, Parratt AC, Krishnakumar S , Sun X, and Kanwa, JR (2009). Promises of nanotechnology for drug delivery to brain in neurodegenerative diseases. Currt Nanoscience. 5(1): 26-32.
- Kanwar JR, Kanwar RK, Burrow H, Baratchi S (2009). Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr Med Chem. 16(19):2373-2394.
- Kanwar ,J.R.and Kanwar RK (2009). Gut health immunomodulatory and anti-inflammatory functions of gut enzyme digested high protein micro-nutrient dietary supplement-Enprocal. BMC Immunol. Jan 31; 10:7.
- Kanwar JR, Kanwar RK, Sun X, Punj V, Matta, H, Morley SM, Parratt A, Puri M. and Sehgal, R (2009). Molecular and biotechnological advances in milk proteins in relation to human health. Curr Protein Peptide Sci. 10(4), 308-338. Invited Review
- Kanwar RK, MacGibbon AK, Black PN, Kanwar JR, Rowan A, Vale M., Krissansen GW.(2008). Bovine milk fat enriched in conjugated linoleic and vaccenic acids attenuates allergic airway disease in mice. Clin Exp Allergy. 38 (1):208-21.
- Kanwar JR, Palmano KP, Sun XY, Kanwar RK, Gupta, R, Haggarty N, Rowan A., Ram S, Krissansen GW (2008). Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy. Immunol Cell Biol. 86 (3): 277-288.
- Krissansen GW, Singh J, Kanwar RK, Leung E, Lehnert KB, Kanwar JR and Yang Y (2006). A pseudosymmetric cell adhesion regulatory domain in the ?7 tail of the integrin ?4?7. European Journal of Immunology 36(8):2203-2214.
- Kanwar JR, Kanwar RK, Krissansen GW (2004). Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 127(6): 1313-1331.
University recorded publications
Researcher output profile for Dr Rupinder Kanwar
Select another contact